Express News | Eli Lilly Shares up 2% Ahead of Q1 Results
Earnings Scheduled For May 1, 2025
Eli Lilly Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
On April 30, the top 20 trading volumes in the U.S. stock market: Super Micro Computer's preliminary Earnings Reports significantly missed expectations.
On Wednesday, Tesla, ranked first in U.S. stock trading volume, closed down 3.38% with a transaction volume of 35.226 billion USD. Data shows that as of the week ending April 27, the number of new registered Tesla electric vehicles in the domestic market was 10,300, a 51% increase from the previous week's 6,780, but down 30.5% compared to the same period last year. NVIDIA, ranked second, closed down 0.09% with a transaction volume of 23.471 billion USD. Super Micro Computer, a manufacturer of AI servers, provided a performance forecast that was far below expectations, raising concerns among investors about weak demand for AI servers, which dragged down stocks like NVIDIA. Meta ranked third.
Eli Lilly's Earnings Report Will Bring a Focus on Tariffs, Not Profits
Eli Lilly Stock Has The Technicals: Will Q1 Earnings Deliver Fundamentals?
Price Over Earnings Overview: Eli Lilly
Market Whales and Their Recent Bets on LLY Options
Eli Lilly Q1 2025 Earnings Preview
Market Rally at Risk as Tariffs Damage Spreads. -2-
Why New Wegovy Deals Won't Restore Novo's Obesity Lead -- Heard on the Street -- WSJ
ELI LILLY Earnings Preview: Recent $LLY Insider Trading, Hedge Fund Activity, and More
Sector Update: Consumer Stocks Rise in Late Afternoon
Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum
Eli Lilly and Company's (NYSE:LLY) P/E Still Appears To Be Reasonable
WW International Partners With LillyDirect Pharmacy Provider to Support Members in Getting Zepbound Vials
Express News | Creyon Bio: Will Receive a $13 Mln Upfront Payment
Express News | Creyon Bio and Lilly Enter Into Rna-Targeted Oligo Therapy Development Collaboration
WeightWatchers Rises on Partnership With Eli Lilly to Enhance Zepbound Access
Hims & Hers, LifeMD Shares Soar 20+% Amid Novo Nordisk Deal for Weight-Loss Drugs